Tuftsin: Its chemistry, biology, and clinical potentia

Critical Reviews in Biochemistry and Molecular Biology

Volumn 24, Issue 1, 1989, Pages 1-40

  Fridkin, Mati ^a   Najjar, Victor A ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUFTSIN;

ADULT; ANIMAL; CHEMISTRY; DOG; DRUG EFFECT; GRANULOCYTE; HUMAN; MACROPHAGE; MOUSE; NEOPLASM; PHYSIOLOGY; REVIEW;

ADULT; ANIMALS; CHEMISTRY; DOGS; GRANULOCYTES; HUMANS; MACROPHAGES; MICE; NEOPLASMS; TUFTSIN;

EID: 84907035896     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.3109/10409238909082550     Document Type: Article

References (205)

1. Tuftsin, a natural and general phagocytosis stimulating peptide-affecting macrophages and polymorphonuclear granulocyte
2. A new phagocytosis stimulating tetrapeptide hormone, tuftsin and its role in diseas
3. Characteristics and isolation of the phagocytosis-stimulating peptide tuftsi
4. The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological propertie
5. A physiological role of the lymphoid system. VII. The disappearance of leucokinin activity following splenectom
6. Anti-tumor effect of tuftsi
7. Tuftsin: a hormone-like tetrapeptide with antimicrobial and antitumor activitie
8. The physiological role of the lymphoid syste
9. The physiological role of γ-globuli
10. The characteristics, isolation and synthesis of phagocytosis-stimulating peptide tuftsi
11. Solid-phase peptide synthesis. I. The synthesis of a tetrapeptid
12. The solid-phase synthesis of tuftsin and its analog
13. Synthesis structure-activity relationships and radioimmunoassay of tuftsi
14. Tuftsin and some analogs. Synthesis and interaction with human polymorphonuclear leukocyte
15. Phagocytosis-stimulating activity of tuftsin analog
16. Nouvelles syntheses et propietes de la tuftsin
17. Bacterial activity of tuftsi
18. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activit
19. Anti-tumor effect of the physiological tetrapeptide tuftsi
20. Toxicology and antitumor activity of tuftsin in mic
21. Toxicology and antitumor activity of tuftsi
22. Initial clinical studies with tuftsi
23. Tuftsin (Thr-Lys-Pro-Arg), a physiological activator of phagocytic cells: a possible role in cancer suppression and therap
24. The antineoplastic effects of tuftsin and tuftsinyltuftsin on B16/5B melanoma and L1210 cell
25. In Vivo and in vitro antitumor activities of tuftsi
26. In Vivo immuno stimulation by tuftsi
27. Immuno pharmacological properties of tuftsin and of some analogue
28. Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatmen
29. Stimulating effect of tuftsin and its analogues on the defective monocyte chemotaxis in systematic lupus elythematosu
30. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: general implications to activation of programmed cell
31. Mediators of cellular immunit
32. Prevention of spontaneous tumors of aged mice by immuno pharmacologic manipulation: study of immune antitumor mechanism
33. Immunorestorative capacity of tuftsin and long-term administration to aging mic
34. Tuftsin stimulates the release of oxygen radicals and thromboxane from macrophage
35. Augmentation of oxidative and arachidonate metabolism in macrophages by tuftsin (Thr-Lys-Pro-Arg
36. Positive correlation between superoxide release and intracellular adenosine deaminase activity during macrophage membrane perturbation regardless of nature or magnitude of stimulu
37. Purine salvage pathway enzyme activity in tuftsin-stimulated macrophage
38. Tuftsin induced tumor necrosis activit
39. On the mechanism of action of phagocytosis-stimulating peptide tuftsi
40. Immunoglobulin-derived drug
41. Tuftsin— a physiological phagocytosis-stimulating peptid
42. Tuftsin, Thr-Lys-Pro-Arg anatomy of an immunologic ally active peptid
43. Tuftsin analogs and their biological activit
44. Synthetic pathways to tuftsin and radioimmunoassa
45. Solid phase peptide synthesi
46. Studies on peptides. XLVIII. Application of the trifluoromethanesulphonic acid procedure to the synthesis of tuftsi
47. 1]tuftsin— a new agonist of the phagocytosis stimulating peptid
48. Synthesis of tuftsin and its analog
49. Polymeric reagents in peptide synthesi
50. The controlled synthesis of peptides in aqueous medium. I. The use of a-amino acid N -carboxyanhydride
51. Calculation of stable conformations of tuftsi
52. 13C nuclear magnetic resonance and circular dichroism studies of tuftsin conformation in wate
53. Conformational investigations in the tuftsin grou
54. Tuftsin and its analogs. VIII. Infrared spectroscopic investigations of tuftsin and its analog
55. Synthesis and properties of tuftsin, L-threonyl-l-lysyl-l-propyl-l-arginin
56. Elongated and cyclic analogs of tuftsin and rigi
57. Conformational energy study of tuftsi
58. Nuclear magnetic resonance studies of the tetrapeptide tuftsin, l-threonyl-l-lysyl-l-prolyl-l-arginine, and its pentapeptide, l-threonyl-l-lysyl-l-prolyl-l-prolyl-l-arginin
59. H-1 and C-13 NMR studies of tuftsin conformatio
60. NMR studies of the conformation of tuftsin and a pentapeptide tuftsin inhibitor in solutio
61. Inactivation of phagocytosis-stimulating activity of tuftsin by polymor-phonuclear neutrophiis. A possible role of leucine aminopeptidase as an ecto-enzym
62. Proline endopeptidase and exopeptidase activity in polymorphonuclear granulocyte
63. The physiological role of the lymphoid system. VI. The stimulatory effect of leucophilic γ-globulin (Leucokinin) on the phagocytic activity of human polymorphonuclear leucocyt
64. The physiological role of the lymphoid system. III. Leucophilic γ-globulin and the phagocytic activity of the polymorphonuclear leucocyt
65. The requirement for membrane sialic acid in the stimulation of phagocytosis by the natural tetrapeptide, tuftsi
66. Tuftsin deficiency syndrome— a report of two new case
67. Defective phagocytosis due to tuftsin deficiency in splenectomized subject
68. Phagocytic activity of the leukemic cell and its response to the phagocytosis stimulating tetrapeptide tuftsi
69. Tuftsin (Thr-Lys-Pro-Arg) a natural modulator of macrophage activity: further studie
70. Tuftsin and its analogs. IV. Synthesis of new tuftsin analogs based on simulation of genetic mutation
71. Tuftsin and its analogs, VI. Biological effect of the substitution of the consecutive residues in the peptide chain by leucin
72. Tuftsin and its analogs. VII. Experimental proof of the hypothesis on functional conservatism in coding of tuftsin sequenc
73. The chemistry and biology of tuftsi
74. Tuftsin a natural activator of phagocytic functions including tumoricidal activit
75. Chromatographic characterization and opsonic activity of bovine erythrophilic and leucophilic γ-globulin
76. Functional tuftsin binding sites on macrophage-like tumor line P388DI and on bone marrow cells differentiated in vitro into mononuclear phagocyte
77. Tuftsin, a natural activator of phagocyte cells: an overvie
78. Effect of tuftsin on the migration, chemotaxis, and differentiation of macrophages and granulocyte
79. Migration enhancement by tuftsin of human mononuclear cells and its effect on the migration inhibition factor test with tumor antigen
80. The effect of tuftsin, its analogs and its conjugates with formyl chemotactic peptide on chemotaxis of human monocyte
81. Methods in laboratory investigation. An in vivo assay for chemoattractant activit
82. Myeloperoxidase-mediated cytotoxic system
83. Active oxygen species and the functions of phagocytic leukocyte
84. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanism
85. In Vivo immuno-pharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogue
86. Restoration of impaired immune functions of aging animals. II. Effect of syngeneic thymus and bone marrow graft
87. Immunological studies of agin
88. Biological effects of tuftsin and its analog
89. Chemotactic and stimulating effect of tuftsin and its analogues on human monocyte
90. The effect of tuftsin on human monocyte cytotoxicit
91. Tuftsin: a naturally occurring immunopotentiating facto
92. Tly role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophil
93. Cyclic nucleotides as modulators of leukocyte chemotaxi
94. Hormonal control of lysosomal enzyme release from human neutrophils: elevation of cyclic nucleotide levels by autonomic neurohormone
95. Mechanisms of lysosomal enzyme release from human leukocyte
96. Modulation of human neutrophil chemotactic responses by cyclic 3′,5′-guanosine monophosphate and cyclic 3′,5′-adenosine monophosphat
97. The tuftsin receptor
98. Effect of immuno modulating agents on leucocyte chemotaxis and cyclic nucleotide
99. Cyclic GMP metabolism and involvement in biological regulatio
100. The importance of calcium ions for the regulation of guanosine 3:5′-cyclic monophosphate level
101. Partial sequence of histones with tuftsin activit
102. The phagocytosis stimulating peptide tuftsin: further look into structure-function relationship
103. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosi
104. Tuftsin stimulation of phagocytosis by the retinal pigment epitheliu
105. Effect of tuftsin on the phagocytosis activity of the unicellular tetrahymena. Does primary interaction develop imprintin
106. Biological aspects of tuftsin activit
107. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocyte
108. Enhancement of phagocytosis— a newfound activity of substance P residing in its N-terminal tetrapeptide sequenc
109. Tuftsin analogs: synthesis, structure-function relationships and implications for specificity of tuftsin's bioactivit
110. Tuftsin (Thr-Lys-Pro-Arg), a natural activator of phagocytosis cells with antibacterial and antineoplastic activit
111. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subject
112. Decreased tuftsin concentrations in patients who have undergone splenectom
113. Decreased serum tuftsin concentration in sickle cell diseas
114. Acquired tuftsin deficienc
115. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicr
116. Interactions of radiolabeled tuftsin with human neutrophil
117. The identification of serum tuftsin by reverse phase— HPLC and mass spectrometr
118. Tuftsin receptor
119. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivative
120. Oxygen-dependent microbial killing by phagocytosi
121. Phagocytosi
122. Quantitative nitroblue tetrazolium test in chronic granulomatons diseas
123. The effect of tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocyte
124. Receptor-mediated endocytosis of tuftsin by macrophage cell
125. Receptor-mediated internalization of tuftsin by human polyrnorphonuclear leukocyte
126. Receptor-mediated internalization of tuftsi
127. Tuftsin binding to various macrophage hybridoma
128. Isolation and characterization of tuftsin recepto
129. Tuftsin (Thr-Lys-Pro-Arg), a stimulator of all known functions of macrophag
130. Isolation and subunit composition of tuftsin recepto
131. Tuftsin analogs for probing its specific receptor site on phagocytic cell
132. Further studies on tuftsin a natural activator of phagocytosis cell
133. Suppression of friend virus-induced leukaemia in mice by tuftsi
134. Inhibition of C1-mediated immunohemolysis by mon-omeric and dimeric peptides from the second constant domain of human immunoglobulin
135. Molecular analysis of spontaneous somatic mutant
136. Inhibition of phagocyte functionsby a synthetic peptide Lys-Pro-Pro-Arg (postin
137. Characterization and synthesis of macrophage inhibitory peptide from the second constant domain of human immunoglobulin
138. Regulatory role of a tripeptide (TKP) from the second constant domain of immunoglobulin G.I. Inhibition of rat and human macrophage activitie
139. Proteolysis of human C-reactive protein produces peptides with potent immuno modulating activit
140. Synthetic peptides from C-reactive protein containing tuftsin-related sequence
141. Structure-function studies of C-reactive protein using synthetic peptidic fragment
142. Tuftsin and its analogues. II. The modification of basic amino acid residues in the peptide chai
143. Synthesis and properties of phagocytosis-stimulating factor, tuftsin and its analogue
144. Rigin, another phagocytosis-stimulating tetrapeptide isolated from human IgG. Confirmations of a hypothesi
145. Biochemistry and physiology of tuftsin Thr-Lys-Pro-Ar
146. Application of synthetic peptides representative of immunoglobulin sequences to the delineation of receptor binding and signalling processe
147. Elongated tuftsin analogues— synthesis and biological investigatio
148. Synthesis and biological investigations of new tuftsin analogs with elongated peptide chai
149. Peptide fragments from the tuftsin containing domain of immunoglobulin G. Synthesis and biological activit
150. Synthesis of tuftsinyl-tuftsin with potential tumoricidal activit
151. Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivative
152. Tetrapeptide promoting phagocytosis activity of leukocyte
153. The design and synthesis of a nonpeptide mimic of an immuno suppressing peptid
154. Antibacterial properties of tuftsin and its analog
155. Application du chlorure de phosphonitirile en synthese peptidiqu
156. The effect of tuftsin in the treatment of experimental pseudomonas keratite
157. Tuftsin enhances clearing of Pseudomonas in experimental corneal infectio
158. Prophylaxis of Candida albicans infection with tuftsi
159. Inhibition by tuftsin of Rauscher virus leukemia development in mic
160. Effect of tuftsin on in vivo development of 3-methylcholanthrene-induced primary fibrosarcoma and Lewis lung carcinoma in mic
161. The effect of tuftsin, an immuno potentiating peptide on cloud man S-91 melanoma, in viv
162. Potentiation of antitumor activity of α-difluoromethyl ornithine by the immunomodulating peptide tuftsi
163. A phase II study of tuftsin for the treatment of non-small cell of the lun
164. − syste
165. The role of the spleen in immunity and infectio
166. Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsi
167. The physiological role of membrane γ-globulin interactio
168. Molecular basis of familial and acquired phagocytosis deficiency involving tetrapeptide, Thr-Lys-Pro-Arg, tuftsi
169. Biochemical aspects of tuftsin deficiency syndrom
170. Tuftsin deficiency: a new syndrome with defective phagocytosi
171. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosi
172. Bacterial meningitis and septicimia in sickle cell diseas
173. Penicillin in sickle cell anemi
174. In Vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of chil
175. The hazard of infection following splenectomy in childre
176. Enhanced adherence of S. pneumoniae and H. influenzae in splenectomized subjects due to tuftsin deficienc
177. Sepsis neonatoru
178. The effect rate after sepsis in a murine of tuftsin and splenectomy on mortality after intraabdominal sepsi
179. Effects of tuftsin on post-splenectomy sepsi
180. 2, or tuftsi
181. Tuftsin stimulates thyrotropin secretion in rat
182. Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayer
183. Enhancement of immunogenic and tumoricidal effects of tuftsin by entrapment in liposome
184. Central effects of tuftsi
185. Central effects of the tetrapeptide tuftsin (transl
186. Comparative study of the psychotropic activity of tuftsin and its analogs (transl
187. 4]-tuftsinyltuftsin, tetrapeptide fragment (1—4) of substance Pand its amid
188. Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia viru
189. Sequence relationship between Rauscher leukemia virus (RLV) p65—70 (gag-gene product) and tuftsin as monitored by the p65—70 proteolitic facto
190. Increased expression of endogenous zenotropic murine retrovirus by treatment with the tetrapeptide tuftsin and kentsi
191. Enhancement of endogenous zenotropic murine retrovirus expression by tuftsi
192. First case of AIDS in a homosexual in Israel. Results of different therapeutic regimen
193. The inhibition of d-glyceraldehyde 3-phosphate dehydrogenase by specific antiseru
194. A study of the competition of lecithin and antitoxin for Cl. welchii lecithinas
195. Production of antibody to Welchii antitoxin that inhibits lecithinase activity of the corresponding toxi